Arkansas Legal Resource Navigator

21 U.S.C. § 387u — Studies of progress and effectiveness

Federal law — U.S. Code and appendices · legal_authorities

21 U.S.C. § 387u — Studies of progress and effectiveness

Page 699 TITLE 21—FOOD AND DRUGS § 387v 1 So in original. Probably should be plural. (A) the actual knowledge that the manu- facturer or distributor had; or (B) the knowledge which a reasonable per- son would have had under like cir- cumstances or which would have been ob- tained upon the exercise of due care. (e) Consultation In carrying out this section, the Secretary shall consult with the Attorney General of the United States and the Secretary of the Treas- ury, as appropriate. (June 25, 1938, ch. 675, § 920, as added Pub. L. 111–31, div. A, title III, § 301, June 22, 2009, 123 Stat. 1850.) Editorial Notes REFERENCES IN TEXT Section 201 of the Family Smoking Prevention and Tobacco Control Act, referred to in subsec. (a)(1), is section 201 of div. A of Pub. L. 111–31. § 387u. Studies of progress and effectiveness (a) FDA report Not later than 3 years after June 22, 2009, and not less than every 2 years thereafter, the Sec- retary of Health and Human Services shall sub- mit to the Committee on Health, Education, Labor, and Pensions of the Senate and the Com- mittee on Energy and Commerce of the House of Representatives, a report concerning— (1) the progress of the Food and Drug Admin- istration in implementing this division, in- cluding major accomplishments, objective measurements of progress, and the identifica- tion of any areas that have not been fully im- plemented; (2) impediments identified by the Food and Drug Administration to progress in imple- menting this division and to meeting statu- tory timeframes; (3) data on the number of new product appli- cations received under section 387j of this title and modified risk product applications re- ceived under section 387k of this title, and the number of applications acted on unde

Source: Supplied 2024 U.S. Code historical extraction · 21 U.S.C. § 387u

Stored review status: historical_2024_not_currentness_verified. A text match is a research starting point; applicability is not established.

Original supplied file — preserved unchanged

Download original Markdown file

File SHA-256: bbec29a803c223e60985a9c4580e78f73c2f6341b2503aff2fdbf8d1a556d7c0. The original may include catalog metadata, neighboring provisions, or embedded records outside this collection's scope. Search shows only the selected federal record. Historical editions and unverified snapshots are not a statement of current law.

Authority boundary: historical or unconfirmed source not current law verified.

Open the recorded source website ↗

Record provenance

Stable record: federal_law:legal_authorities:usc2024-96c50a92c55c57f5102c9dea
Source file: Laws/federal/codes/united-states-code-2024/title-21/section-387u-studies-of-progress-and-effectiveness--4745b3b5dd.md
Pages: Not recorded – Not recorded
Passage SHA-256: f767c46c694b8a1fc3e6cccfc6ac8e481691a1b02b11fbea6daf5c143979d93b

Source location: USCODE-2024-title21-chap9-subchapIX-sec387u.pdf

Stored source content

Page 699 TITLE 21—FOOD AND DRUGS § 387v 1 So in original. Probably should be plural. (A) the actual knowledge that the manu- facturer or distributor had; or (B) the knowledge which a reasonable per- son would have had under like cir- cumstances or which would have been ob- tained upon the exercise of due care. (e) Consultation In carrying out this section, the Secretary shall consult with the Attorney General of the United States and the Secretary of the Treas- ury, as appropriate. (June 25, 1938, ch. 675, § 920, as added Pub. L. 111–31, div. A, title III, § 301, June 22, 2009, 123 Stat. 1850.) Editorial Notes REFERENCES IN TEXT Section 201 of the Family Smoking Prevention and Tobacco Control Act, referred to in subsec. (a)(1), is section 201 of div. A of Pub. L. 111–31. § 387u. Studies of progress and effectiveness (a) FDA report Not later than 3 years after June 22, 2009, and not less than every 2 years thereafter, the Sec- retary of Health and Human Services shall sub- mit to the Committee on Health, Education, Labor, and Pensions of the Senate and the Com- mittee on Energy and Commerce of the House of Representatives, a report concerning— (1) the progress of the Food and Drug Admin- istration in implementing this division, in- cluding major accomplishments, objective measurements of progress, and the identifica- tion of any areas that have not been fully im- plemented; (2) impediments identified by the Food and Drug Administration to progress in imple- menting this division and to meeting statu- tory timeframes; (3) data on the number of new product appli- cations received under section 387j of this title and modified risk product applications re- ceived under section 387k of this title, and the number of applications acted on under each category; and (4) data on the number of full time equiva- lents engaged in implementing this division. (b) GAO report Not later than 5 years after June 22, 2009, the Comptroller General of the United States shall conduct a study of, and submit to the Commit- tees described in subsection (a) a report con- cerning— (1) the adequacy of the authority and re- sources provided to the Secretary of Health and Human Services for this division to carry out its goals and purposes; and (2) any recommendations for strengthening that authority to more effectively protect the public health with respect to the manufacture, marketing, and distribution of tobacco prod- ucts. (c) Public availability The Secretary of Health and Human Services and the Comptroller General of the United States, respectively, shall make the reports re- quired under subsection 1 (a) and (b) available to the public, including by posting such reports on the respective Internet websites of the Food and Drug Administration and the Government Ac- countability Office. (Pub. L. 111–31, div. A, title I, § 106, June 22, 2009, 123 Stat. 1841.) Editorial Notes REFERENCES IN TEXT This division, referred to in subsecs. (a)(1), (2), (4) and (b)(1), is div. A of Pub. L. 111–31, June 22, 2009, 123 Stat. 1776, known as Family Smoking Prevention and To- bacco Control Act. For complete classification of divi- sion A to the Code, see Short Title of 2009 Amendment note set out under section 301 of this title and Tables. CODIFICATION Section was enacted as part of the Family Smoking Prevention and Tobacco Control Act, and not as part of the Federal Food, Drug, and Cosmetic Act which com- prises this chapter. Statutory Notes and Related Subsidiaries MODIFICATION OF DEADLINES FOR SECRETARIAL ACTION With respect to any time periods specified in div. A of Pub. L. 111–31 that begin on June 22, 2009, within which the Secretary of Health and Human Services is required to carry out and complete specified activities, with certain limitations, the calculation of such time periods shall commence on the first day of the first fis- cal quarter following the initial 2 consecutive fiscal quarters of fiscal year 2010 for which the Secretary has collected fees under section 387s of this title, and the Secretary may extend or reduce the duration of one or more such time periods, except that no such period shall be extended for more than 90 days, see section 6 of Pub. L. 111–31, set out as a note under section 387 of this title. § 387v. Reporting on tobacco regulation activities (a) In general For fiscal year 2022 and each subsequent fiscal year for which fees are collected under section 387s of this title, the Secretary of Health and Human Services shall, not later than 180 days after the end of the fiscal year, prepare and sub- mit to the Committee on Energy and Commerce and the Committee on Appropriations of the House of Representatives, and the Committee on Health, Education, Labor, and Pensions and the Committee on Appropriations of the Senate, an annual report that contains the information re- quired under subsection (b). (b) Required information Each report submitted under subsection (a) shall contain the following information for the previous fiscal year: (1) Total annual user fee collections. (2) Total amount of fees obligated. (3) The amount of unobligated carryover bal- ance from fees collected. (4) The amount obligated by the Center for Tobacco Products for each of the following ac- tivities: (A) Compliance and enforcement. (B) Public education campaigns. (C) Scientific research and research infra- structure.

Cross-references

Connections may be documented source relationships, shared citations or nearby passages. Each explains its basis; a connection alone does not establish applicability to your situation.

Federal law — U.S. Code and appendices · legal_authorities

21 U.S.C. § 387u — Studies of progress and effectiveness

**(a) FDA report** Not later than 3 years after June 22, 2009, and not less than every 2 years thereafter, the Secretary of Health and Human Services shall submit to the Committee on Health, Education, Labor, and Pensions of the Senate and the Committee on Energy and Commerce of the House of Representatives, a report concerning— (1) the progress of the Food and Drug Administration in implementing this division, including major accomplishments, objective measurements of progress, and the identification of any areas that have not been fully implemented; (2) impediments identified by the Food and Drug Administration to progress in implementing this division and to meeting statutory timeframes; (3) data on the number of new product applications received under [section 387j of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section387j&num=0&edition=prelim) and modified risk product applications received under [section 387k of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section387k&num=0&edition=prelim), and the number of applications acted on under each category; and (4) data on the number of full time equivalents engaged in implementing this division. **(b) GAO report** Not later than 5 years after June 22, 2009, the Comptroller General of the United States shall conduct a study of, and submit to the Committees described in subsection (a) a report concerning— (1) the adequacy of the authority and resources provided to the Secretary of Health and Human Services for this division to carry out its goals and purposes; and (2) any recommendations for strengthening that authority to more effectively protect the public health with respect to the manufacture, marketing, and distribution of tobacco product

Source: Supplied U.S. Code snapshot — release unconfirmed · 21 U.S.C. § 387u

Stored review status: release_metadata_unconfirmed. Same stored citation; legal effect and authority still require review.